Company News
Embecta Downgraded to B as Revenue Falls 14%
S&P cut Embecta’s rating to ‘B’ from ‘B+’, citing a 14% Q2 FY2026 revenue drop.
Pen‑needle sales fell ~20% constant‑currency, with share loss to a lower‑cost provider at a major U.S. retailer.
S&P for
